ResMed Inc (ASX: RMD) shares got hammered this last year. Here’s why the ASX 200 healthcare share looks poised for an ...

ASX healthcare shares surged 21% over the past month. Can CSL, ResMed, and Cochlear keep climbing into the future?

You can also use https://gitlab1s.com or https://npmjs1s.com in the same way. For browser extensions, see Third-party Related Projects. Or save the following code ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...

Shares of medical device company ResMed (NYSE:RMD) jumped 3.7% in the afternoon session after it was added to Goldman Sachs' ...

Air Voel continues to strengthen its commitment to improving sleep health for Canadians by providing dependable ResMed BiPAP ...

ResMed (RMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks ...

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock ...

The ASX 200 index rose just 2.8 per cent before dividends in the 2025-26 financial year, its weakest result since a 10 per ...

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure ...

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $200.00 Call had some of the highest implied ...